Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines

• Hisayo Nishida-Fukuda ,

  Roles Data curation, Formal analysis, Funding acquisition, Investigation, Writing – original draft

  * E-mail: h-tanaka@niu.ac.jp (HT); fukudahs@hirakata.kmu.ac.jp (HNF)

  Affiliation Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Hirakata City, Osaka, Japan

  https://orcid.org/0000-0002-4661-779X

  ⨯
• Keizo Tokuhiro,

  Roles Funding acquisition, Writing – review & editing

  Affiliation Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Hirakata City, Osaka, Japan

  ⨯
• Yukio Ando,

  Roles Resources

  Affiliation Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki, Japan

  ⨯
• Hiroaki Matsushita,

  Roles Resources

  Affiliation Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki, Japan

  ⨯
• Morimasa Wada,

  Roles Resources

  Affiliation Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki, Japan

  ⨯
• Hiromitsu Tanaka

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  * E-mail: h-tanaka@niu.ac.jp (HT); fukudahs@hirakata.kmu.ac.jp (HNF)

  Affiliation Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki, Japan

  ⨯